Personalizing Cancer Drugs Market 2027 By Technology, Application, End User and Geography | The Insight Partners

Personalizing Cancer Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Technology (Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Others); Application (Breast Cancer, Prostrate Cancer, Lung Cancer, Others); End User (Hospitals, Research Institutes, Oncology Clinics, Others) and Geography

Report Code: TIPRE00017481 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Personalized drugs can be defined as a type of treatment that focuses on the individual physiognomies of each patient. Personalized medicine utilizes a patient's characteristics and preferences to help determine the drugs needed. Personalized medicines also offer companion diagnostic tests, a category of laboratory tests that uses a patient's genetic information to help physicians identify customized treatment options. Personalizing cancer drugs possesses a huge prospective in leading the healthcare industry with substantial modifications and alterations with prime emphasis on the understanding & management of affected cancer integrated with advanced analytics, patient data, tailored medicines, and other possibilities. They have also used genetic information to develop tests for cancer and ways to prevent it. Personalized cancer drugs can have fewer side effects than different types of treatment. This is because it is designed to be more specific. Personalized medicine may affect healthy cells less and cells involved in cancer more.

MARKET DYNAMICS

The personalizing cancer drugs market has shown a significant evolution over the forecast period. The rise of the personalizing cancer drug market is majorly driven by the increasing prevalence of various kinds of cancer. As per data provided by GLOBOCAN 2018, the global burden of cancer increased to 18.1 million new cases. The rising cancer-related spending is also amongst the drivers for growth. Moreover, the number of gene therapies, medicines, and diagnostics introduced in this arena has increased significantly over the last couple of years due to the growing prevalence of life-threatening medical conditions, especially cancer and rare diseases. Since personalized medicine has been helping target cancerous tissues, the scope of personalized medicine is expected to grow exponentially over the forecast period. Apart from this, lesser side effects and a high adoption rate in developed markets will also boost personalized cancer drugs in the global market. However, factors such as a limited number of collaborations, constant regulatory oversight, lack of awareness regarding personalized medicine, and unstable legal network are likely to impede the market growth.

MARKET SCOPE

The "Personalizing Cancer Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry's pharmaceutical, with a specific focus on the global market trend analysis. This report provides an outline of the personalizing cancer drugs market with detailed market segmentation by technology, application, and end-user. The personalizing cancer drugs market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the personalizing cancer drugs market and offers key opportunities and trends in the market.

MARKET SEGMENTATION

The market is categorized based on the technology, application, and end user. Based on the technology, the market is segmented as pharmacogenomics, point-of-care testing, stem cell therapy, and others. Based on the application, the segmentation of the market is into breast cancer, prostrate cancer, lung cancer, and others. Based on end user, segmentation of the market is into hospitals, research institutes, oncology clinics, and others.

REGIONAL FRAMEWORK

The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the personalizing cancer drugs market based on various segments. The report also consists of market size and forecast estimates from the year 2018 to2027with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The personalizing cancer drugs market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the personalizing cancer drugs market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the personalizing cancer drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report contains critical developments in the personalizing cancer drugs market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like technology approvals, technology launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the personalizing cancer drugs market are anticipated to have profitable growth opportunities in the following years with the increasing demand for personalizing cancer drugs in the global market. Below mentioned is the list of a few companies engaged in the personalizing cancer drugs market.
The report also offers key players' profiles in the personalizing cancer drugs market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

  •  GENERAL ELECTRIC
  •  Illumina, Inc.
  •  ASURAGEN, INC.
  •  Abbott Laboratories.
  •  Dako A/S
  •  Exact Sciences Corporation
  •  Danaher
  •  deCODE genetics
  •  Genelex Corporation
  •  Precision Biologics.

The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Personalizing Cancer Drugs Market - By Technology
1.3.2 Personalizing Cancer Drugs Market - By Application
1.3.3 Personalizing Cancer Drugs Market - By End User
1.3.4 Personalizing Cancer Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PERSONALIZING CANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PERSONALIZING CANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PERSONALIZING CANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PERSONALIZING CANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. PERSONALIZING CANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PERSONALIZING CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PHARMACOGENOMICS
7.3.1. Overview
7.3.2. Pharmacogenomics Market Forecast and Analysis
7.4. POINT-OF-CARE TESTING
7.4.1. Overview
7.4.2. Point-of-Care Testing Market Forecast and Analysis
7.5. STEM CELL THERAPY
7.5.1. Overview
7.5.2. Stem Cell Therapy Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PERSONALIZING CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BREAST CANCER
8.3.1. Overview
8.3.2. Breast Cancer Market Forecast and Analysis
8.4. PROSTRATE CANCER
8.4.1. Overview
8.4.2. Prostrate Cancer Market Forecast and Analysis
8.5. LUNG CANCER
8.5.1. Overview
8.5.2. Lung Cancer Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PERSONALIZING CANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Research Institutes Market Forecast and Analysis
9.5. ONCOLOGY CLINICS
9.5.1. Overview
9.5.2. Oncology Clinics Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. PERSONALIZING CANCER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Personalizing Cancer Drugs Market Overview
10.1.2 North America Personalizing Cancer Drugs Market Forecasts and Analysis
10.1.3 North America Personalizing Cancer Drugs Market Forecasts and Analysis - By Technology
10.1.4 North America Personalizing Cancer Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Personalizing Cancer Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Personalizing Cancer Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Personalizing Cancer Drugs Market
10.1.6.1.1 United States Personalizing Cancer Drugs Market by Technology
10.1.6.1.2 United States Personalizing Cancer Drugs Market by Application
10.1.6.1.3 United States Personalizing Cancer Drugs Market by End User
10.1.6.2 Canada Personalizing Cancer Drugs Market
10.1.6.2.1 Canada Personalizing Cancer Drugs Market by Technology
10.1.6.2.2 Canada Personalizing Cancer Drugs Market by Application
10.1.6.2.3 Canada Personalizing Cancer Drugs Market by End User
10.1.6.3 Mexico Personalizing Cancer Drugs Market
10.1.6.3.1 Mexico Personalizing Cancer Drugs Market by Technology
10.1.6.3.2 Mexico Personalizing Cancer Drugs Market by Application
10.1.6.3.3 Mexico Personalizing Cancer Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Personalizing Cancer Drugs Market Overview
10.2.2 Europe Personalizing Cancer Drugs Market Forecasts and Analysis
10.2.3 Europe Personalizing Cancer Drugs Market Forecasts and Analysis - By Technology
10.2.4 Europe Personalizing Cancer Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Personalizing Cancer Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Personalizing Cancer Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Personalizing Cancer Drugs Market
10.2.6.1.1 Germany Personalizing Cancer Drugs Market by Technology
10.2.6.1.2 Germany Personalizing Cancer Drugs Market by Application
10.2.6.1.3 Germany Personalizing Cancer Drugs Market by End User
10.2.6.2 France Personalizing Cancer Drugs Market
10.2.6.2.1 France Personalizing Cancer Drugs Market by Technology
10.2.6.2.2 France Personalizing Cancer Drugs Market by Application
10.2.6.2.3 France Personalizing Cancer Drugs Market by End User
10.2.6.3 Italy Personalizing Cancer Drugs Market
10.2.6.3.1 Italy Personalizing Cancer Drugs Market by Technology
10.2.6.3.2 Italy Personalizing Cancer Drugs Market by Application
10.2.6.3.3 Italy Personalizing Cancer Drugs Market by End User
10.2.6.4 Spain Personalizing Cancer Drugs Market
10.2.6.4.1 Spain Personalizing Cancer Drugs Market by Technology
10.2.6.4.2 Spain Personalizing Cancer Drugs Market by Application
10.2.6.4.3 Spain Personalizing Cancer Drugs Market by End User
10.2.6.5 United Kingdom Personalizing Cancer Drugs Market
10.2.6.5.1 United Kingdom Personalizing Cancer Drugs Market by Technology
10.2.6.5.2 United Kingdom Personalizing Cancer Drugs Market by Application
10.2.6.5.3 United Kingdom Personalizing Cancer Drugs Market by End User
10.2.6.6 Rest of Europe Personalizing Cancer Drugs Market
10.2.6.6.1 Rest of Europe Personalizing Cancer Drugs Market by Technology
10.2.6.6.2 Rest of Europe Personalizing Cancer Drugs Market by Application
10.2.6.6.3 Rest of Europe Personalizing Cancer Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Personalizing Cancer Drugs Market Overview
10.3.2 Asia-Pacific Personalizing Cancer Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Personalizing Cancer Drugs Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Personalizing Cancer Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Personalizing Cancer Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Personalizing Cancer Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Personalizing Cancer Drugs Market
10.3.6.1.1 Australia Personalizing Cancer Drugs Market by Technology
10.3.6.1.2 Australia Personalizing Cancer Drugs Market by Application
10.3.6.1.3 Australia Personalizing Cancer Drugs Market by End User
10.3.6.2 China Personalizing Cancer Drugs Market
10.3.6.2.1 China Personalizing Cancer Drugs Market by Technology
10.3.6.2.2 China Personalizing Cancer Drugs Market by Application
10.3.6.2.3 China Personalizing Cancer Drugs Market by End User
10.3.6.3 India Personalizing Cancer Drugs Market
10.3.6.3.1 India Personalizing Cancer Drugs Market by Technology
10.3.6.3.2 India Personalizing Cancer Drugs Market by Application
10.3.6.3.3 India Personalizing Cancer Drugs Market by End User
10.3.6.4 Japan Personalizing Cancer Drugs Market
10.3.6.4.1 Japan Personalizing Cancer Drugs Market by Technology
10.3.6.4.2 Japan Personalizing Cancer Drugs Market by Application
10.3.6.4.3 Japan Personalizing Cancer Drugs Market by End User
10.3.6.5 South Korea Personalizing Cancer Drugs Market
10.3.6.5.1 South Korea Personalizing Cancer Drugs Market by Technology
10.3.6.5.2 South Korea Personalizing Cancer Drugs Market by Application
10.3.6.5.3 South Korea Personalizing Cancer Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Personalizing Cancer Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Personalizing Cancer Drugs Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Personalizing Cancer Drugs Market by Application
10.3.6.6.3 Rest of Asia-Pacific Personalizing Cancer Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Personalizing Cancer Drugs Market Overview
10.4.2 Middle East and Africa Personalizing Cancer Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Personalizing Cancer Drugs Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Personalizing Cancer Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Personalizing Cancer Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Personalizing Cancer Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Personalizing Cancer Drugs Market
10.4.6.1.1 South Africa Personalizing Cancer Drugs Market by Technology
10.4.6.1.2 South Africa Personalizing Cancer Drugs Market by Application
10.4.6.1.3 South Africa Personalizing Cancer Drugs Market by End User
10.4.6.2 Saudi Arabia Personalizing Cancer Drugs Market
10.4.6.2.1 Saudi Arabia Personalizing Cancer Drugs Market by Technology
10.4.6.2.2 Saudi Arabia Personalizing Cancer Drugs Market by Application
10.4.6.2.3 Saudi Arabia Personalizing Cancer Drugs Market by End User
10.4.6.3 U.A.E Personalizing Cancer Drugs Market
10.4.6.3.1 U.A.E Personalizing Cancer Drugs Market by Technology
10.4.6.3.2 U.A.E Personalizing Cancer Drugs Market by Application
10.4.6.3.3 U.A.E Personalizing Cancer Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Personalizing Cancer Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Personalizing Cancer Drugs Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Personalizing Cancer Drugs Market by Application
10.4.6.4.3 Rest of Middle East and Africa Personalizing Cancer Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Personalizing Cancer Drugs Market Overview
10.5.2 South and Central America Personalizing Cancer Drugs Market Forecasts and Analysis
10.5.3 South and Central America Personalizing Cancer Drugs Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Personalizing Cancer Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Personalizing Cancer Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Personalizing Cancer Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Personalizing Cancer Drugs Market
10.5.6.1.1 Brazil Personalizing Cancer Drugs Market by Technology
10.5.6.1.2 Brazil Personalizing Cancer Drugs Market by Application
10.5.6.1.3 Brazil Personalizing Cancer Drugs Market by End User
10.5.6.2 Argentina Personalizing Cancer Drugs Market
10.5.6.2.1 Argentina Personalizing Cancer Drugs Market by Technology
10.5.6.2.2 Argentina Personalizing Cancer Drugs Market by Application
10.5.6.2.3 Argentina Personalizing Cancer Drugs Market by End User
10.5.6.3 Rest of South and Central America Personalizing Cancer Drugs Market
10.5.6.3.1 Rest of South and Central America Personalizing Cancer Drugs Market by Technology
10.5.6.3.2 Rest of South and Central America Personalizing Cancer Drugs Market by Application
10.5.6.3.3 Rest of South and Central America Personalizing Cancer Drugs Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. PERSONALIZING CANCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. GENERAL ELECTRIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASURAGEN, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT LABORATORIES.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DAKO A/S
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EXACT SCIENCES CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DANAHER
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DECODE GENETICS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENELEX CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PRECISION BIOLOGICS.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GENERAL ELECTRIC
2. Illumina, Inc.
3. ASURAGEN, INC.
4. Abbott Laboratories.
5. Dako A/S
6. Exact Sciences Corporation
7. Danaher
8. deCODE genetics
9. Genelex Corporation
10. Precision Biologics.
TIPRE00017481
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking